Zolendronate in osteogenesis imperfecta

Journal of Pediatric Endocrinology and Metabolism

Volumn 22, Issue 8, 2009, Pages 763-

  Panigrahi, Inusha ^a   Das, Rashmi Ranjan ^a   Marwaha, Ram Kumar ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

UNCLASSIFIED DRUG; ZOLE TRUST; ZOLEDRONIC ACID;

BONE DENSITY; DRUG COST; DRUG EFFICACY; DRUG SAFETY; DUAL ENERGY X RAY ABSORPTIOMETRY; HUMAN; LETTER; OSTEOGENESIS IMPERFECTA; SCORING SYSTEM; WILCOXON SIGNED RANKS TEST;

EID: 70349480702     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.2009.22.8.763     Document Type: Letter

References (2)

1. Brown JJ, Zacharin MR. Safety and efficacy of intravenous zolendronic acid in paediatric osteoporosis. J Pediatr Endocrinol Metab 2009; 22: 55-63.
2. Adami S, Zamberlan N. Adverse effects of bisphosphonates: a comparative review. Drug Saf 1996; 14: 158-170. (Pubitemid 126426313)